Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Vivianna M. Van Deerlin, MD, PhD

Vivianna M. Van Deerlin, MD, PhD

faculty photo
Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Department: Pathology and Laboratory Medicine

Contact information
Hospital of the University of Pennsylvania
Department of Pathology and Laboratory Medicine
7.103 Founders Pavilion
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-662-6644
Fax: 215-662-7529
Education:
M.S. (Biochemistry)
University of Chicago, 1986.
B.S. (Chemistry)
University of Chicago, 1986.
M.D. (Medical Scientist Training Program, MSTP)
Washington University School of Medicine, 1994.
Ph.D. (MSTP/Molecular Cell Biology and Biochemistry)
Washington University School of Medicine, 1994.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Description of Research Expertise

My research interests are focused in the genetics of neurodegenerative diseases, in particular frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and Alzheimer's disease (AD). My lab partners with Penn neurologists working in these areas and the Center for Neurodegenerative Diseases for neuropathology and biochemistry to collect DNA from living individuals and brains from autopsy cases to conduct genetic and genome-wide studies to better understand these diseases and identify therapeutic targets. We also work with 2 genetic counselors and have a special interest in the education of patients and the translation of the genetic findings from research labs to CLIA-certified clinical labs so it can benefit patients and families in our research cohort as well as the population at large.

FTLD manifests clinically with progressive behavioral and/or language deficits. Subtypes of FTLD are classified neuropathologically by the protein composition of cellular inclusion bodies. The most common neuropathological correlates of FTLD have TAR DNA binding protein (TDP-43) inclusions (FTLD-TDP) or tau inclusions (FTLD-tau). FTLD is frequently familial and can occur as an autosomal dominantly inherited disorder. Genes with mutations causing FTLD include MAPT (encodes tau) and GRN (encodes progranulin) among others, each of which is associated with a specific FTLD pathological subtype: GRN mutations with FTLD-TDP and MAPT mutations with FTLD-tau. Studying the genetics of FTLD can help elucidate its etiology and pathophysiology and provide targets for therapy as well as identify risk factors that modify disease risk or phenotype. We perform genetic analysis of FTLD, ALS, PD, and AD to identify mutations in known genes as well as novel genes and study them in families to determine pathogenicity, phenotypic variability and correlations with brain pathology. Several recent major projects led to teh identicication of TARDBP (TDP-43) mutations in ALS and a genome-wide association study of FTLD-TDP which identified a novel genetic risk factor, TMEM106B. Many new avenues of research in these areas are being pursued.

Description of Clinical Expertise

My clinical expertise is in Molecular Pathology. The clinical laboratory I direct is a full service CLIA certified molecular pathology laboratory that encompasses testing in all areas including oncology (hematological and solid tumor), infectious diseases, genetics, hereditary and somatic pharmacogenetics, and identity testing. Currently we have a major emphasis on the development of oncology-based tests including somatic pharmacogenetics. Somatic pharmacogenetics represents somatic changes in tumors that make them more or less susceptible to therapeutic approaches. With the development of new targeted therapies, this type of molecular oncology testing is ever more critical for clinical management of patients. Other areas of growth include molecular infectious disease testing.

In addition, our Department and Lab sponsor a fellowship training program in Molecular Genetic Pathology to train the next generation of molecular laboratory directors and surgical pathologists with expertise in the integration of molecular technologies into the practice of pathology.

Selected Publications

Diamond Joshua M, Cantu Edward, Porteous Mary, Suzuki Yoshikazu, Meyer Keith C, Lederer David, Milewski Rita K, Arcasoy Selim, D'Ovidio Frank, Bacchetta Matthew, Sonett Joshua R, Singh Gopal, Costa Joseph, Tobias John W, Rodriguez Hetty, Van Deerlin Vivianna M, Olthoff Kim M, Shaked Abraham, Chang Bao-Li, Christie Jason D: Peripheral Blood Gene Expression Changes Associated with Primary Graft Dysfunction after Lung Transplantation. Am J Transplant Jan 2017 [Epub ahead of print]

Cairns NJ, Irwin DJ, Van Deerlin VM, Lee VM-Y, Trojanowski JQ : Genetics and Neuropathology of Frontotemporal Dementia. The Human Frontal Lobes: Functions and Disorders. Miller BL, Cummings JL (eds.). Guilford Publications, Inc. 2017 [in press] Notes: 3rd Edition

Lee Edward B, Porta Sílvia, Michael Baer G, Xu Yan, Suh EunRan, Kwong Linda K, Elman Lauren, Grossman Murray, Lee Virginia M-Y, Irwin David J, Van Deerlin Vivianna M, Trojanowski John Q: Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol Jan 2017 [Epub ahead of print]

Jun Gyungah R, Chung Jaeyoon, Mez Jesse, Barber Robert, Beecham Gary W, Bennett David A, Buxbaum Joseph D, Byrd Goldie S, Carrasquillo Minerva M, Crane Paul K, Cruchaga Carlos, De Jager Philip, Ertekin-Taner Nilufer, Evans Denis, Fallin M Danielle, Foroud Tatiana M, Friedland Robert P, Goate Alison M, Graff-Radford Neill R, Hendrie Hugh, Hall Kathleen S, Hamilton-Nelson Kara L, Inzelberg Rivka, Kamboh M Ilyas, Kauwe John S K, Kukull Walter A, Kunkle Brian W, Kuwano Ryozo, Larson Eric B, Logue Mark W, Manly Jennifer J, Martin Eden R, Montine Thomas J, Mukherjee Shubhabrata, Naj Adam, Reiman Eric M, Reitz Christiane, Sherva Richard, St George-Hyslop Peter H, Thornton Timothy, Younkin Steven G, Vardarajan Badri N, Wang Li-San, Wendlund Jens R, Winslow Ashley R, Haines Jonathan, Mayeux Richard, Pericak-Vance Margaret A, Schellenberg Gerard, Lunetta Kathryn L, Farrer Lindsay A: Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimer's & dementia : the journal of the Alzheimer's Association Feb 2017 Notes: Member of the ADGC.

Cooper Christine A, Jain Nimansha, Gallagher Michael D, Weintraub Daniel, Xie Sharon X, Berlyand Yosef, Espay Alberto J, Quinn Joseph, Edwards Karen L, Montine Thomas, Van Deerlin Vivianna M, Trojanowski John, Zabetian Cyrus P, Chen-Plotkin Alice S: Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype. Ann Clin Transl Neurology 4(1): 15-25, Jan 2017.

Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ: Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol Jan 2017.

Suh E*, Lee EB*, Neal D, Wood EM, Toledo JB, Rennert L, Irwin DJ, McMillan CT, Krock B, Elman LB, McCluskey LF, Grossman M, Xie SX, Trojanowski JQ, and Van Deerlin VM: Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration. Acta Neuropathol 130(3): 363-72, Sept 2015 Notes: *These authors contributed equally to this work.

Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, Wood EM, Grossman M, McCluskey L, Clark CM, Neumann M, Danek A, Galasko DR, Arnold SE, Chen-Plotkin A, Karydas A, Miller BL, Trojanowski JQ, Lee VM, Schellenberg GD, Van Deerlin VM: The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol 67(2): 161-70, Feb 2010.

Van Deerlin VM, Sleiman PMA, Martinez-Lage M, Chen-Plotkin A, Wang, L-S, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DMA, Pickering-Brown SM, Seelaar H, Heutink P, vanSwieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, Gilman S, Lieberman AP, Kaye JA, Woltjer Randall L, Bigio EH, Mesulam M, Al-Sarraj S, Troakes C, Rosenberg RN, White III CL, Ferrer I, Lladó A, Neumann M, Kretzschmar HA, Hulette CM, Welsh-Bohmer KA, Miller, BL, Alzualde A, de Munain Lopez A, McKee AC, Gearing M, Levey AI, Lah JJ, Hardy J, Rohrer JD, Lashley T, Mackenzie IRA, Feldman HH, Hamilton RL, Dekosky ST, van der Zee J, Kumar-Singh S, Van Broeckhoven C, Mayeux R, Vonsattel JPG, Troncoso JC, Kril JJ, Kwok JBJ, Halliday GM, Bird TD, Ince PG, Shaw PJ, Cairns NJ, Morris JC, McLean CA, DeCarli C, Ellis WG, Freeman SH, Frosch MP, Growdon JH, Perl DP, Sano M, Bennett DA, Schneider JA, Beach TG, Reiman EM, Woodruff BK, Cummings J, Vinters HV, Miller CA, Chui HC, Alafuzoff I, Hartikainen P, Seilhean D, Galasko D, Masliah E, Cotman CW, Tuñón MT, Caballero Martínez MC, Munoz DG, Carroll SL, Marson D, Riederer PF, Bogdanovic N, Schellenberg GD, Hakonarson H, Trojanowski JQ and Lee VM-Y.: Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 42(3): 234–39, Mar 2010 Notes: First 4 authors are co-first authors.

back to top
Last updated: 03/23/2017
The Trustees of the University of Pennsylvania